Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.03 USD
Change Today 0.00 / 0.00%
Volume 265.0K
EKSO On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

ekso bionics holdings inc (EKSO) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/1/15 - $2.34
52 Week Low
10/1/14 - $0.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

ekso bionics holdings inc (EKSO) Related Bloomberg News

View More Bloomberg News

ekso bionics holdings inc (EKSO) Related Businessweek News

No Related Businessweek News Found

ekso bionics holdings inc (EKSO) Details

Ekso Bionics Holdings, Inc. designs, develops, and sells wearable robots or exoskeletons for use in the medical, military, industrial, and consumer markets in North America, Western Europe, the Middle East, and South Africa. The company operates through Engineering Services and Medical segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, stroke, and other lower-extremity paralysis or weakness. The company’s Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a collaborative partnership with Lockheed Martin Corporation to develop products for military applications, as well as a license agreement with Otto Bock Healthcare Products Gmbh. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in Richmond, California.

67 Employees
Last Reported Date: 04/6/15
Founded in 2005

ekso bionics holdings inc (EKSO) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $401.1K
President and Chief Commercial Officer
Total Annual Compensation: $201.7K
Co-Founder and President of Ekso Labs Divisio...
Total Annual Compensation: $323.0K
Chief Financial Officer
Total Annual Compensation: $323.0K
Compensation as of Fiscal Year 2014.

ekso bionics holdings inc (EKSO) Key Developments

Ekso Bionics Holdings, Inc. to Reveal New SmartAssist Software At DMGP in Kassel, Germany

Ekso Bionics Holdings, Inc. announced that the latest Ekso Bionics robotic gait therapy software upgrade, first available in Europe, will be revealed at the 28th Annual Meeting of the German Speaking Medical Society for Paraplegia (DMGP) in Kassel, Germany. Ekso GT with SmartAssist features include: the next generation of adaptive assistance software, enabling a greater number of interactive steps; PreGait, a suite of early mobilization activities for pre-ambulatory patients preparing for gait therapy; and FreeGait, an advanced mode for patients progressing to community ambulation. This new Ekso GT package will also support integration of Functional Electric Stimulation (FES) from Hasomed for research use, providing the opportunity for facilities operating under research protocols to partner with Ekso to advance research on complimentary therapies. Ekso GT with new SmartAssist software supports a broader spectrum of patients who are more actively engaged in their rehabilitation. The new SmartAssist programming provides patients with an unparalleled ability to vary the step path based on their own effort. High step variability has been associated with enhanced locomotor rehabilitation. The company's commercial plan anticipates an initial launch of the SmartAssist robotic gait therapy software package for Ekso GT in Europe by the end of 2015. The SmartAssist software is not yet available in the United States.

Ekso Bionics Seeks Acquisitions

Ekso Bionics Holdings, Inc. (OTCBB:EKSO) has filed a Shelf Registration in the amount of $75.00 million. Unless otherwise indicated in the applicable prospectus supplement, Ekso intends to use any net proceeds from the sale of securities under this prospectus in the development and commercialization of able-bodied exoskeletons for industrial use, and for other general corporate purposes, including, but not limited to, working capital, intellectual property protection and enforcement, capital expenditures, investments, acquisitions and collaborations.

Ekso Bionics Holdings, Inc. Secures Third Contract with the U.S. Special Operations Command

Ekso Bionics Holdings, Inc. announced that their Ekso Labs division secured a third contract with the United States Special Operations Command (SOCOM) to work on the next phase of the Tactical Assault Light Operator Suit (TALOS) project. Following the completion of a previous SOCOM project, the latest will focus on the development of an upper extremity part for TALOS Mk III. Additionally the US Patent Office has now granted Ekso Bionics three new patents resulting from their work on DARPA and other government agency projects. SOCOM announced last year that it was working to create a wearable uniform, which provides superhuman capabilities with superior mobility and protection, for their Special Operations Forces. U.S. Special Operations Command is moving forward in the development of its exoskeleton that would give Special Forces troops head-to-toe ballistic protection while allowing for fluid movements. Ekso Bionics designs, develops, and commercializes exoskeletons, or wearable robots, which have a variety of applications in the medical, military, industrial, and consumer markets. Exoskeletons are ready-to-wear, battery-powered robots that are strapped over the user's clothing, enabling individuals to achieve mobility, strength, and endurance not otherwise possible.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EKSO:US $1.03 USD 0.00

EKSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥1,531 JPY +17.00
Parker-Hannifin Corp $112.75 USD +0.17
ReWalk Robotics Ltd $10.52 USD +0.18
Rex Bionics PLC 57.50 GBp 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation EKSO Industry Range
Price/Earnings 2.0x
Price/Sales 17.6x
Price/Book 5.5x
Price/Cash Flow 2.4x
TEV/Sales 14.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EKSO BIONICS HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at